NCT01480180 · Interventional trial
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Overall registry status Completed
Phase 3
Conditions Congenital Bleeding Disorder, Haemophilia A
Delaware Valley sites
- Novo Nordisk Investigational Site · Philadelphia, PA · Philadelphia County
- Novo Nordisk Investigational Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory